China Shineway Pharmaceutical Group Ltd ($2877) - buy or sell? Stock discussion, ideas, forum

China Shineway Pharmaceutical Group Ltd

China Shineway Pharmaceutical Group Limited develops, manufactures, and sells modern Chinese medicines in the Peoples Republic of China.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$2877	HKEx Main Board	KYG2110P1000	Code: 2877

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 2877 stock

Share your investment idea or question on China Shineway Pharmaceutical Group Ltd stock:

Latest twits on China Shineway Pharmaceutical Group Ltd (2877)

No twits yet. Be the first to post!

Have a question about 2877? Ask and other investors will be eager to help you.

Have an idea about 2877? Share it with other investors.

China Shineway Pharmaceutical Group Ltd news

30/03/2016 China Shineway Pharmaceutical Group Ltd reports 16.5% CAPEX growth while 7.8% Revenue decline

China Shineway Pharmaceutical Group Ltd stock price chart

China Shineway Pharmaceutical Group Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	2,038	1,985	2,132
EBITDA	996.9	949.5	806.2
Net income	821.8	755.6	647.7
CAPEX	368.8	396.6	368.9
Debt	0.000	0.000	0.000
Cash	2,349	2,173	2,212

China Shineway Pharmaceutical Group Ltd news

30/03/2016 China Shineway Pharmaceutical Group Ltd reports 16.5% CAPEX growth while 7.8% Revenue decline

About China Shineway Pharmaceutical Group Ltd

China Shineway Pharmaceutical Group Limited develops, manufactures, and sells modern Chinese medicines in the Peoples Republic of China. The Company also produces and sells a series of western pharmaceuticals.